Real-world experience with anti–programmed cell death protein 1 immunotherapy in patients with esophageal cancer: A retrospective single-center study

by Xinpeng Wang, Xinpeng Wang, Lvjuan Cai, Lvjuan Cai, Mengjing Wu, Mengjing Wu, Guo Li, Guo Li, Yunyun Zhu, Yunyun Zhu, Xinyue Lin, Xinyue Lin, Xue Yan, Xue Yan, Peng Mo, Peng Mo, Huachun Luo, Huachun Luo, Zhichao Fu, Zhichao Fu
Published 2022-09-01